278 related articles for article (PubMed ID: 37186121)
1. FDA-approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness.
Canepa E; Parodi-Rullan R; Vazquez-Torres R; Gamallo-Lana B; Guzman-Hernandez R; Lemon NL; Angiulli F; Debure L; Ilies MA; Østergaard L; Wisniewski T; Gutiérrez-Jiménez E; Mar AC; Fossati S
Alzheimers Dement; 2023 Nov; 19(11):5048-5073. PubMed ID: 37186121
[TBL] [Abstract][Full Text] [Related]
2. Amyloid Beta Oligomers Activate Death Receptors and Mitochondria-Mediated Apoptotic Pathways in Cerebral Vascular Smooth Muscle Cells; Protective Effects of Carbonic Anhydrase Inhibitors.
Anzovino A; Canepa E; Alves M; Lemon NL; Carare RO; Fossati S
Cells; 2023 Dec; 12(24):. PubMed ID: 38132159
[TBL] [Abstract][Full Text] [Related]
3. The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain.
Fossati S; Giannoni P; Solesio ME; Cocklin SL; Cabrera E; Ghiso J; Rostagno A
Neurobiol Dis; 2016 Feb; 86():29-40. PubMed ID: 26581638
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibition selectively prevents amyloid β neurovascular mitochondrial toxicity.
Solesio ME; Peixoto PM; Debure L; Madamba SM; de Leon MJ; Wisniewski T; Pavlov EV; Fossati S
Aging Cell; 2018 Aug; 17(4):e12787. PubMed ID: 29873184
[TBL] [Abstract][Full Text] [Related]
5. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
[TBL] [Abstract][Full Text] [Related]
6. Fruquintinib/HMPL-013 ameliorates cognitive impairments and pathology in a mouse model of cerebral amyloid angiopathy (CAA).
Zhou G; Xiang T; Xu Y; He B; Wu L; Zhu G; Xie J; Yao L; Xiao Z
Eur J Pharmacol; 2023 Jan; 939():175446. PubMed ID: 36470443
[TBL] [Abstract][Full Text] [Related]
7. Cross-talk between Aβ and endothelial SSAO/VAP-1 accelerates vascular damage and Aβ aggregation related to CAA-AD.
Solé M; Miñano-Molina AJ; Unzeta M
Neurobiol Aging; 2015 Feb; 36(2):762-75. PubMed ID: 25457560
[TBL] [Abstract][Full Text] [Related]
8. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Parodi-Rullán R; Sone JY; Fossati S
J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
[TBL] [Abstract][Full Text] [Related]
9. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease.
Bourassa P; Tremblay C; Schneider JA; Bennett DA; Calon F
Acta Neuropathol; 2019 May; 137(5):801-823. PubMed ID: 30729296
[TBL] [Abstract][Full Text] [Related]
10. A1 reactive astrocytes and a loss of TREM2 are associated with an early stage of pathology in a mouse model of cerebral amyloid angiopathy.
Taylor X; Cisternas P; You Y; You Y; Xiang S; Marambio Y; Zhang J; Vidal R; Lasagna-Reeves CA
J Neuroinflammation; 2020 Jul; 17(1):223. PubMed ID: 32711525
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial calcium uptake 3 mitigates cerebral amyloid angiopathy-related neuronal death and glial inflammation by reducing mitochondrial dysfunction.
Zhou G; Ye Q; Xu Y; He B; Wu L; Zhu G; Xie J; Yao L; Xiao Z
Int Immunopharmacol; 2023 Apr; 117():109614. PubMed ID: 36878048
[TBL] [Abstract][Full Text] [Related]
12. Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Tanaka M; Saito S; Inoue T; Satoh-Asahara N; Ihara M
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183348
[TBL] [Abstract][Full Text] [Related]
13. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
[TBL] [Abstract][Full Text] [Related]
14. Effects of cerebral amyloid angiopathy on the brain vasculome.
Deng W; Guo S; van Veluw SJ; Yu Z; Chan SJ; Takase H; Arai K; Ning M; Greenberg SM; Lo EH; Bacskai BJ
Aging Cell; 2022 Aug; 21(8):e13503. PubMed ID: 35851991
[TBL] [Abstract][Full Text] [Related]
15. Long-term voluntary wheel running does not alter vascular amyloid burden but reduces neuroinflammation in the Tg-SwDI mouse model of cerebral amyloid angiopathy.
Robison LS; Popescu DL; Anderson ME; Francis N; Hatfield J; Sullivan JK; Beigelman SI; Xu F; Anderson BJ; Van Nostrand WE; Robinson JK
J Neuroinflammation; 2019 Jul; 16(1):144. PubMed ID: 31296239
[TBL] [Abstract][Full Text] [Related]
16. Blocking the apolipoprotein E/amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice.
Yang J; Ji Y; Mehta P; Bates KA; Sun Y; Wisniewski T
J Alzheimers Dis; 2011; 24(2):269-85. PubMed ID: 21239853
[TBL] [Abstract][Full Text] [Related]
17. Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow.
Li H; Guo Q; Inoue T; Polito VA; Tabuchi K; Hammer RE; Pautler RG; Taffet GE; Zheng H
Mol Neurodegener; 2014 Aug; 9():28. PubMed ID: 25108425
[TBL] [Abstract][Full Text] [Related]
18. Potential Role of Venular Amyloid in Alzheimer's Disease Pathogenesis.
Morrone CD; Bishay J; McLaurin J
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183293
[TBL] [Abstract][Full Text] [Related]
19. Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia.
Haglund M; Kalaria R; Slade JY; Englund E
Acta Neuropathol; 2006 May; 111(5):430-5. PubMed ID: 16555084
[TBL] [Abstract][Full Text] [Related]
20. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
